23 June 2022 - 11:00AM CET
In recent years, Advanced Therapy Medicinal Products (ATMPs) have evolved into a promising and highly hoped-for medical approach to cure a broad spectrum of diseases, ranging from cancer to immunological disorders and rare diseases.
From development, collection, manufacturing, and infusion back into the patient, the journey of a cell therapy requires intricate logistics to maintain product integrity and patient safety. Challenges and requirements can vary according to the specific type of therapy, and a deep understanding of the end-to-end workflow is critical.
Following harvest from the patient, cells can either be shipped fresh (2ºc to 8ºc) or cryopreserved and stored for later use.
Join experts from Albumedix, Cytiva, Miltenyi Biomedicine, and World Courier to learn more about:
The logistics challenges and solutions for fresh or frozen cell shipments and the reasons to choose one approach over the other
How to extend the shelf life of cells
Innovations in shipping and storage
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
